Indivior Pharmaceuticals, Inc. (INDV)
31.51
-1.01
(-3.11%)
USD |
NASDAQ |
Apr 16, 16:00
31.49
-0.02
(-0.06%)
After-Hours: 20:00
Indivior Pharmaceuticals Cash from Investing (Quarterly) : -22.46M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | -1.403M |
| Catalyst Pharmaceuticals, Inc. | -0.032M |
| Liquidia Corp. | -4.038M |
| Pulse Biosciences, Inc. | -0.105M |
| Ultragenyx Pharmaceutical, Inc. | -72.25M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -226.38M |
| Cash from Financing (Quarterly) | -5.638M |
| Free Cash Flow | -94.86M |
| Free Cash Flow Per Share (Quarterly) | -1.999 |
| Free Cash Flow to Equity (Quarterly) | -244.85M |
| Free Cash Flow to Firm (Quarterly) | -242.29M |
| Free Cash Flow Yield | -2.38% |